Contents

Current Vascular Pharmacology, Volume 14 - Number 5

Editorial

Meet Our Editorial Board Member:

, 14(5): 405

Gaetano Santulli


DOI: 10.2174/138955751617161006172636




Editorial

Editorial (Thematic Issue: Sex, Environment, Physical Activity, Diet, and Obesity in Cardiovascular Disease Risk)

, 14(5): 406 - 408

Debabrata Mukherjee and Thomas F. Whayne


DOI: 10.2174/138955751617161006172905




Impact of Chronic Kidney Disease on Risk for Vascular Events

, 14(5): 409 - 414

Jerry Fan and Hasan Salameh


DOI: 10.2174/1570161114999160719104512





Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk

, 14(5): 415 - 425

Sarmad Said, Debabrata Mukherjee and Thomas F. Whayne


DOI: 10.2174/1570161114666160722121615





Use of Chronic Disease Registries to Optimize Cardiovascular Health

, 14(5): 426 - 431

Sucheta Gosavi and Aparna Bhagavat


DOI: 10.2174/1570161114666160722114413





Abnormal Peri-Organ or Intra-organ Fat (APIFat) Deposition: An Underestimated Predictor of Vascular Risk?

, 14(5): 432 - 441

Niki Katsiki, Vasilios G. Athyros and Dimitri P. Mikhailidis


DOI: 10.2174/1570161114666160722112738





The Mediterranean and other Dietary Patterns in Secondary Cardiovascular Disease Prevention: A Review

, 14(5): 442 - 451

Demosthenes B. Panagiotakos, Venetia Notara, Matina Kouvari and Christos Pitsavos


DOI: 10.2174/1570161114999160719104731





Cardiovascular Risk Factors: Does Sex Matter?

, 14(5): 452 - 457

Gretchen L. Wells


DOI: 10.2174/1570161114666160722113116





Increased Exercise Favorably Modifies Coronary Artery Disease and Peripheral Arterial Disease Outcomes

, 14(5): 458 - 465

Thomas F. Whayne and Debabrata Mukherjee


DOI: 10.2174/1570161114999160719104936





Editorial

Editorial: Time for Earlier and More Intensive Preventive Therapy

, 14(5): 466 - 468

Kosmas I. Paraskevas and J. David Spence


DOI: 10.2174/1570161114666160909161319




Editorial

Editorial: Do Some Glucagon-Like-Peptide-1 Receptor Agonists (GLP-1 RA) Reduce Macrovascular Complications of Type 2 Diabetes Mellitus? (A Commentary on the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) Trial)

, 14(5): 469 - 473

Vasilios G. Athyros, Niki Katsiki and Nikolaos Tentolouris


DOI: 10.2174/1570161114666160909161537




Plasma VEGF and IL-8 Levels in Patients with Mixed Dyslipidaemia. Effect of Rosuvastatin Monotherapy or its Combination at a Lower Dose with Omega-3 Fatty Acids: A Pilot Study

, 14(5): 474 - 480

Vasileios G. Chantzichristos, Aris P. Agouridis, Elisavet Moutzouri, Konstantinos Stellos, Moses S. Elisaf and Alexandros D. Tselepis


DOI: 10.2174/1570161114666160404125341





Impact of Ivabradine on Health-Related Quality of Life of Patients with Ischaemic Chronic Heart Failure

, 14(5): 481 - 486

Mansour Sallam, Tariq Al-Saadi, Latifa Alshekaili and Ibrahim Al-Zakwani


DOI: 10.2174/1570161114666160505143003





Lack of Evidence for Deterioration in Endothelial Function Following Ticagrelor Treatment Cessation

, 14(5): 487 - 491

Ioanna Xanthopoulou, Chrysoula Vogiatzi, Theodora Bampouri, Athina Chasapi, Ilianna Bei, Periklis Davlouros, George Hahalis and Dimitrios Alexopoulos


DOI: 10.2174/1570161114666160625084427





Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science